Help
RSS
API
Feed
Maltego
Contact
Domain > antispam.niropharm.org
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-10-25
66.96.144.190
(
ClassC
)
Port 80
HTTP/1.1 200 OKDate: Fri, 25 Oct 2024 16:37:42 GMTContent-Type: text/html; charsetutf-8Content-Length: 28447Connection: keep-aliveServer: ApacheX-Powered-By: PHP/7.4.10Set-Cookie: a7f1eeda1b6f9b7c5ce2803e0595a7d1rqd221beaojcr4s1b1198ppiu2dn4if9; path/; HttpOnlyX-Logged-In: FalseX-Content-Powered-By: K2 v2.10.3 (by JoomlaWorks)Expires: Wed, 17 Aug 2005 00:00:00 GMTLast-Modified: Fri, 25 Oct 2024 16:37:42 GMTCache-Control: no-store, no-cache, must-revalidate, post-check0, pre-check0Pragma: no-cacheAge: 2 !doctype html>html prefixog: http://ogp.me/ns# langen-gb dirltr>head>meta charsetutf-8>meta nameviewport contentwidthdevice-width, initial-scale1, shrink-to-fitno>link relcanonical hrefhttp://antispam.niropharm.org/>base hrefhttp://antispam.niropharm.org/ />meta http-equivcontent-type contenttext/html; charsetutf-8 />meta namedescription contentDemo Helix />meta namegenerator contentHELIX_ULTIMATE_GENERATOR_TEXT />title>Niropharm - Home/title>link href/images/loginNlogin.png relshortcut icon typeimage/vnd.microsoft.icon />link relstylesheet typetext/css href/media/plg_jchoptimize/cache/css/11f1b7a5293dc51393d88ed1f09a25b2.css />script typeapplication/json classjoomla-script-options new>{csrf.token:66b85f10df1b72404bf89389e0641abd,data:{breakpoints:{tablet:991,mobile:480},header:{stickyOffset:100}},system.paths:{root:,base:}}/script>meta propertyog:title contentHome />meta propertyog:type contentwebsite />meta propertyog:url contenthttp://antispam.niropharm.org/ />meta propertyog:site_name contentNiropharm />meta nametwitter:card contentsummary />meta nametwitter:site contentNiropharm />/head>body classsite helix-ultimate hu com-sppagebuilder view-page layout-default task-none itemid-101 en-gb ltr sticky-header layout-fluid offcanvas-init offcanvs-position-right>div classbody-wrapper>div classbody-innerwrapper>header idsp-header>div classcontainer>div classcontainer-inner>div classrow>div idsp-logo classcol-8 col-lg-3>div classsp-column>div classlogo>a href/>img classlogo-image d-none d-lg-inline-block src/images/nirophlogo.jpg altNiropharm>img classlogo-image-phone d-inline-block d-lg-none src/images/nirophlogo.jpg altNiropharm>/a>/div>/div>/div>div idsp-menu classcol-4 col-lg-9>div classsp-column>nav classsp-megamenu-wrapper rolenavigation>a idoffcanvas-toggler aria-labelNavigation classoffcanvas-toggler-right href#>i classfa fa-bars aria-hiddentrue titleNavigation>/i>/a>ul classsp-megamenu-parent menu-animation-fade-up d-none d-lg-block>li classsp-menu-item current-item active>a aria-currentpage href/index.php >Home/a>/li>li classsp-menu-item>a href/index.php/about-niropharm >About Us/a>/li>li classsp-menu-item>a href/index.php/news-blog >News Blog/a>/li>li classsp-menu-item>a href/index.php/contact >Contact Us/a>/li>/ul>/nav>/div>/div>/div>/div>/div>/header>section idsp-section-1 >div classrow>div idsp-title classcol-lg-12 >div classsp-column >/div>/div>/div>/section>section idsp-main-body >div classrow>main idsp-component classcol-lg-12 >div classsp-column >div idsystem-message-container>/div>div idsp-page-builder classsp-page-builder page-1>div classpage-content>section idlt-slider classsppb-section lt-slider >div classsppb-row-overlay>/div>div classsppb-row-container>div classsppb-row>div classsppb-col-sm-12 idcolumn-wrap-id-1511613809>div idcolumn-id-1511613809 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587056618327 classsppb-addon-wrapper>div idsppb-addon-1587056618327 classclearfix >div classsppb-addon sppb-addon-module >div classsppb-addon-content>!-- START REVOLUTION SLIDER 5.0.16 fullwidth mode -->div idrev_slider_1_1_wrapper classrev_slider_wrapper fullwidthbanner-container stylemargin:0px auto;background-color:#E9E9E9;padding:0px;margin-top:0px;margin-bottom:0px;max-height:730px;>div idrev_slider_1_1 classrev_slider fullwidthabanner styledisplay:none;max-height:730px;height:730px;>ul> !-- SLIDE 1-->li data-transitionfade data-slotamount7 data-masterspeed300 data-thumbhttp://antispam.niropharm.org/images/uniterevolution/home-slider/slide1.jpg data-saveperformanceoff idlt-slider data-titleSlide>!-- MAIN IMAGE -->img srchttp://antispam.niropharm.org/images/uniterevolution/home-slider/slide1.jpg altslide1 data-bgpositioncenter top data-bgfitcover data-bgrepeatno-repeat>!-- LAYERS -->!-- LAYER NR. 1 -->div classtp-caption medium_light_white tp-fade tp-resizeme lt-slider-color data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 5; max-width: none; max-height: none; white-space: nowrap;>Forward thinking for your /div>!-- LAYER NR. 2 -->div classtp-caption roundedimage tp-fade tp-resizeme data-x150 data-ycenter data-voffset7 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 6; max-width: 700px; max-height: none; white-space: normal;>Etiam scelerisque tortor at lectus dapibus, nec fermentum diam feugiat.Morbi rutrum magna et dui feugiat, non tristique mi convallis liquam. /div>!-- LAYER NR. 3 -->div classtp-caption large_bold_black sfr tp-resizeme data-x150 data-ycenter data-voffset-82 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 7; max-width: none; max-height: none; white-space: nowrap;>better incomes /div>!-- LAYER NR. 4 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn left data-x150 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 8; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/about-niropharm > Read More/a>/div>!-- LAYER NR. 5 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn right data-x350 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 9; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/contact > Contact Us/a>/div>!-- LAYER NR. 6 -->div classtp-caption tp-fade data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 10;>img srchttp://antispam.niropharm.org/images/uniterevolution/home-slider/business-home-rev-slider-07.png alt>/div>!-- LAYER NR. 7 -->div classtp-caption sfr lt-slider-img-bottom data-x-137 data-y668 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 11;>img srchttp://antispam.niropharm.org/images/uniterevolution/home-slider/main-home-rev-slider-img-02.png alt data-ww1690 data-hh62>/div>/li>!-- SLIDE 2-->li data-transitionfade data-slotamount7 data-masterspeed300 data-thumbhttp://antispam.niropharm.org/images/uniterevolution/home-slider/slide2.jpg data-saveperformanceoff idlt-slider data-titleSlide>!-- MAIN IMAGE -->img srchttp://antispam.niropharm.org/images/uniterevolution/home-slider/slide2.jpg altslide2 data-bgpositioncenter top data-bgfitcover data-bgrepeatno-repeat>!-- LAYERS -->!-- LAYER NR. 1 -->div classtp-caption medium_light_white tp-fade tp-resizeme lt-slider-color data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 5; max-width: none; max-height: none; white-space: nowrap;>We are mainly focused on making /div>!-- LAYER NR. 2 -->div classtp-caption roundedimage tp-fade tp-resizeme data-x150 data-ycenter data-voffset7 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 6; max-width: 700px; max-height: none; white-space: normal;>Etiam scelerisque tortor at lectus dapibus, nec fermentum diam feugiat.Morbi rutrum magna et dui feugiat, non tristique mi convallis liquam. /div>!-- LAYER NR. 3 -->div classtp-caption large_bold_black sfr tp-resizeme data-x150 data-ycenter data-voffset-82 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 7; max-width: none; max-height: none; white-space: nowrap;>your company better /div>!-- LAYER NR. 4 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn left data-x150 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 8; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/pages/our-services > Read More/a>/div>!-- LAYER NR. 5 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn right data-x350 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 9; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/contact > Contact Us/a>/div>!-- LAYER NR. 6 -->div classtp-caption tp-fade data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 10;>img srchttp://antispam.niropharm.org/images/uniterevolution/home-slider/business-home-rev-slider-07.png alt>/div>!-- LAYER NR. 7 -->div classtp-caption sfr lt-slider-img-bottom data-x-137 data-y668 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 11;>img srchttp://antispam.niropharm.org/images/uniterevolution/home-slider/main-home-rev-slider-img-02.png alt data-ww1690 data-hh62>/div>/li>!-- SLIDE 3-->li data-transitionfade data-slotamount7 data-masterspeed300 data-thumbhttp://antispam.niropharm.org/images/uniterevolution/home-slider/slide3.jpg data-saveperformanceoff idlt-slider data-titleSlide>!-- MAIN IMAGE -->img srchttp://antispam.niropharm.org/images/uniterevolution/home-slider/slide3.jpg altslide3 data-bgpositioncenter top data-bgfitcover data-bgrepeatno-repeat>!-- LAYERS -->!-- LAYER NR. 1 -->div classtp-caption medium_light_white tp-fade tp-resizeme lt-slider-color data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 5; max-width: none; max-height: none; white-space: nowrap;>BEST OF Business Planning /div>!-- LAYER NR. 2 -->div classtp-caption roundedimage tp-fade tp-resizeme data-x150 data-ycenter data-voffset7 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 6; max-width: 700px; max-height: none; white-space: normal;>Etiam scelerisque tortor at lectus dapibus, nec fermentum diam feugiat.Morbi rutrum magna et dui feugiat, non tristique mi convallis liquam. /div>!-- LAYER NR. 3 -->div classtp-caption large_bold_black sfr tp-resizeme data-x150 data-ycenter data-voffset-82 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 7; max-width: none; max-height: none; white-space: nowrap;>Advisors & Specialists /div>!-- LAYER NR. 4 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn left data-x150 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 8; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/pages/about-us > Read More/a>/div>!-- LAYER NR. 5 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn right data-x350 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 9; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/contact > Contact Us/a>/div>!-- LAYER NR. 6 -->div classtp-caption tp-fade data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 10;>img srchttp://antispam.niropharm.org/images/uniterevolution/home-slider/business-home-rev-slider-07.png alt>/div>!-- LAYER NR. 7 -->div classtp-caption sfr lt-slider-img-bottom data-x-137 data-y668 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 11;>img srchttp://antispam.niropharm.org/images/uniterevolution/home-slider/main-home-rev-slider-img-02.png alt data-ww1690 data-hh62>/div>/li>/ul>div classtp-bannertimer tp-bottom styledisplay:none; visibility: hidden !important;>/div> /div>/div>!-- END REVOLUTION SLIDER --> /div>/div>/div>/div>/div>/div>/div>/div>/div>/section>section idlt-service classsppb-section lt-service lt-blog sppb-section-content-center >div classsppb-row-overlay>/div>div classsppb-row-container>div classsppb-section-title sppb-text-left>h2 classsppb-title-heading>NEWS/h2>p classsppb-title-subheading>PHARMA IN THE NEWS/p>/div>div classsppb-row sppb-align-center>div classsppb-col-md-12 idcolumn-wrap-id-1519278520250>div idcolumn-id-1519278520250 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587096872075 classsppb-addon-wrapper>div idsppb-addon-1587096872075 classclearfix >div classsppb-addon sppb-addon-module >div classsppb-addon-content>div idk2ModuleBox103 classk2ItemsBlock>ul>li classeven>!-- Plugins: BeforeDisplay -->!-- K2 Plugins: K2BeforeDisplay -->a classmoduleItemTitle href/index.php/news-blog/item/736-new-lung-cancer-drug-cuts-death-risk-by-half-study-finds>New Lung cancer drug cuts death risk by half, study finds/a>!-- Plugins: AfterDisplayTitle -->!-- K2 Plugins: K2AfterDisplayTitle -->!-- Plugins: BeforeDisplayContent -->!-- K2 Plugins: K2BeforeDisplayContent -->div classmoduleItemIntrotext>a classmoduleItemImage href/index.php/news-blog/item/736-new-lung-cancer-drug-cuts-death-risk-by-half-study-finds titleContinue reading "New Lung cancer drug cuts death risk by half, study finds">img src/media/k2/items/cache/3de37b3f2de6564a2ea064ec2afe25d4_M.jpg altNew Lung cancer drug cuts death risk by half, study finds />/a>/div>div classclr>/div>div classclr>/div>!-- Plugins: AfterDisplayContent -->!-- K2 Plugins: K2AfterDisplayContent -->span classmoduleItemDateCreated> Written on Monday, 05 June 2023 15:06 /span>a classmoduleItemReadMore href/index.php/news-blog/item/736-new-lung-cancer-drug-cuts-death-risk-by-half-study-finds> Read more... /a>!-- Plugins: AfterDisplay -->!-- K2 Plugins: K2AfterDisplay -->div classclr>/div>/li>li classodd>!-- Plugins: BeforeDisplay -->!-- K2 Plugins: K2BeforeDisplay -->a classmoduleItemTitle href/index.php/news-blog/item/735-group-urges-tinubu-to-strengthen-implement-tobacco-control-laws>Group urges Tinubu to strengthen, implement tobacco control laws/a>!-- Plugins: AfterDisplayTitle -->!-- K2 Plugins: K2AfterDisplayTitle -->!-- Plugins: BeforeDisplayContent -->!-- K2 Plugins: K2BeforeDisplayContent -->div classmoduleItemIntrotext>a classmoduleItemImage href/index.php/news-blog/item/735-group-urges-tinubu-to-strengthen-implement-tobacco-control-laws titleContinue reading "Group urges Tinubu to strengthen, implement tobacco control laws">img src/media/k2/items/cache/4c704b823894e663c696fb5ee0a8793f_M.jpg?t20230602_124754 altGroup urges Tinubu to strengthen, implement tobacco control laws />/a>/div>div classclr>/div>div classclr>/div>!-- Plugins: AfterDisplayContent -->!-- K2 Plugins: K2AfterDisplayContent -->span classmoduleItemDateCreated> Written on Friday, 02 June 2023 12:36 /span>a classmoduleItemReadMore href/index.php/news-blog/item/735-group-urges-tinubu-to-strengthen-implement-tobacco-control-laws> Read more... /a>!-- Plugins: AfterDisplay -->!-- K2 Plugins: K2AfterDisplay -->div classclr>/div>/li>li classeven lastItem>!-- Plugins: BeforeDisplay -->!-- K2 Plugins: K2BeforeDisplay -->a classmoduleItemTitle href/index.php/news-blog/item/734-prioritise-local-drug-manufacturing-health-insurance-stakeholders-task-tinubu>Prioritise local drug manufacturing, health insurance, stakeholders task Tinubu/a>!-- Plugins: AfterDisplayTitle -->!-- K2 Plugins: K2AfterDisplayTitle -->!-- Plugins: BeforeDisplayContent -->!-- K2 Plugins: K2BeforeDisplayContent -->div classmoduleItemIntrotext>a classmoduleItemImage href/index.php/news-blog/item/734-prioritise-local-drug-manufacturing-health-insurance-stakeholders-task-tinubu titleContinue reading "Prioritise local drug manufacturing, health insurance, stakeholders task Tinubu">img src/media/k2/items/cache/52847945d34c24d045f4f6bfeae5a17d_M.jpg?t20230601_071355 altPrioritise local drug manufacturing, health insurance, stakeholders task Tinubu />/a>/div>div classclr>/div>div classclr>/div>!-- Plugins: AfterDisplayContent -->!-- K2 Plugins: K2AfterDisplayContent -->span classmoduleItemDateCreated> Written on Wednesday, 31 May 2023 12:57 /span>a classmoduleItemReadMore href/index.php/news-blog/item/734-prioritise-local-drug-manufacturing-health-insurance-stakeholders-task-tinubu> Read more... /a>!-- Plugins: AfterDisplay -->!-- K2 Plugins: K2AfterDisplay -->div classclr>/div>/li>li classclearList>/li>/ul>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/section>section idlt-project classsppb-section lt-project >div classsppb-row-overlay>/div>div classsppb-row-container>div classsppb-row>div classsppb-col-md-6 idcolumn-wrap-id-1587310143530>div idcolumn-id-1587310143530 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587310143535 classsppb-addon-wrapper>div idsppb-addon-1587310143535 classclearfix >div classsppb-addon sppb-addon-single-image sppb-text-center lt-project-img>div classsppb-addon-content>div classsppb-addon-single-image-container>img classsppb-img-responsive src/images/2021/07/12/home1c.png altPresident giving a speech during the donation of COVID19 Relief Drugs to FG title loadinglazy>/div>/div>/div>/div>/div>div idsppb-addon-wrapper-1587321820480 classsppb-addon-wrapper>div idsppb-addon-1587321820480 classclearfix >div classsppb-addon sppb-addon-single-image sppb-text-center lt-project-img-pen>div classsppb-addon-content>div classsppb-addon-single-image-container>img classsppb-img-responsive src/images/2020/04/19/business-home-rev-slider-img-05.png altImage title loadinglazy>/div>/div>/div>/div>/div>/div>/div>/div>div classsppb-col-md-6 idcolumn-wrap-id-1587310143531>div idcolumn-id-1587310143531 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587310143541 classsppb-addon-wrapper>div idsppb-addon-1587310143541 classclearfix >div classsppb-addon sppb-addon-text-block lt-project-content lt-title-content>h5 classsppb-addon-title>A Responsible, Active and People FocusedHealthcare Advocacy Organisation. /h5>div classsppb-addon-content>h2>Developing people. Delivering results./h2>p>Niropharm member organizations believe in working to improve healthcare indices and take active practical steps to support and be corporately responsible for the health of the citizens in very direct and tangible ways. /p>/div>/div>/div>/div>div idsppb-addon-wrapper-1587318290840 classsppb-addon-wrapper>div idsppb-addon-1587318290840 classclearfix >div classsppb-text-left>a href/index.php/pages/about-us idbtn-1587318290840 classsppb-btn lt-btn sppb-btn-default sppb-btn-rounded>Read More/a>/div>/div>/div>/div>/div>/div>/div>/div>/section>section idlt-about classsppb-section lt-about >div classsppb-row-overlay>/div>div classsppb-row-container>div classsppb-row>div classsppb-col-md-4 idcolumn-wrap-id-1519278764263>div idcolumn-id-1519278764263 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1519279129419 classsppb-addon-wrapper>div idsppb-addon-1519279129419 classclearfix >div classsppb-addon sppb-addon-feature sppb-text-left lt-about-item>div classsppb-addon-content sppb-text-left>div classsppb-media>div classpull-left>div classsppb-icon>span classsppb-icon-container aria-labelMarket Size>i classfa fa-street-view aria-hiddentrue>/i>/span>/div>/div>div classsppb-media-body>div classsppb-media-content>h3 classsppb-addon-title sppb-feature-box-title sppb-media-heading>Market Size/h3>div classsppb-addon-text>NIROPHARM Market Size in Nigeria is $218m (source BMI monitor, 2006) and this is constantly growing due to the opportunities and market potentials./div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>div classsppb-col-md-4 idcolumn-wrap-id-1519278764264>div idcolumn-id-1519278764264 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587321820472 classsppb-addon-wrapper>div idsppb-addon-1587321820472 classclearfix >div classsppb-addon sppb-addon-feature sppb-text-left lt-about-item>div classsppb-addon-content sppb-text-left>div classsppb-media>div classpull-left>div classsppb-icon>span classsppb-icon-container aria-labelPharma Imports>i classfas fa-funnel-dollar aria-hiddentrue>/i>/span>/div>/div>div classsppb-media-body>div classsppb-media-content>h3 classsppb-addon-title sppb-feature-box-title sppb-media-heading>Pharma Imports/h3>div classsppb-addon-text>Imports of Pharmaceutical products constitute 70% of the Nigerian Pharma industry./div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>div classsppb-col-md-4 idcolumn-wrap-id-1519278764265>div idcolumn-id-1519278764265 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587321820469 classsppb-addon-wrapper>div idsppb-addon-1587321820469 classclearfix >div classsppb-addon sppb-addon-feature sppb-text-left lt-about-item>div classsppb-addon-content sppb-text-left>div classsppb-media>div classpull-left>div classsppb-icon>span classsppb-icon-container aria-labelLocal Manufacture>i classfas fa-mortar-pestle aria-hiddentrue>/i>/span>/div>/div>div classsppb-media-body>div classsppb-media-content>h3 classsppb-addon-title sppb-feature-box-title sppb-media-heading>Local Manufacture/h3>div classsppb-addon-text>Local Manufacture accounts for the remaining 30% of pharmaceuticals in the country/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/section>/div>/div>/div>/main>/div>/section>section idsp-bottom >div classcontainer>div classcontainer-inner>div classrow>div idsp-bottom1 classcol-sm-col-sm-6 col-lg-12 >div classsp-column >div classsp-module >h3 classsp-module-title>Information/h3>div classsp-module-content>div classcustom >p>strong>NIROPHARM/strong> is dedicated to working to improve and enhance the quality of service to the Nation, public (local and international) Image, and the scope of the Nigerian Pharmaceutical Industry who face a number of challenges. /p>p>Some of the challenges that NIROPHRM is set to tackle with all the resources it has at its disposal include: High cost of funds, Poor infrastructure, Poor IPR protection, Chaotic drug distribution, Lack of data for planning, High level of Counterfeiting, Low capacity of Regulatory Agencies, Regulatory Agency, not computerized, Poor surveillance particularly at the land borders/p>/div>/div>/div>/div>/div>/div>/div>/div>/section>footer idsp-footer >div classcontainer>div classcontainer-inner>div classrow>div idsp-footer1 classcol-lg-12 >div classsp-column >span classsp-copyright>div aligncenter>a target_blank titleDesigned and Powered by hrefhttps://www.tishritechnologies.com relauthor nofollow>Tishri InfoTech Nig Ltd/a>/div>/span>/div>/div>/div>/div>/div>/footer> /div>/div>!-- Off Canvas Menu -->div classoffcanvas-overlay>/div>div classoffcanvas-menu>a href# classclose-offcanvas>span classfa fa-remove>/span>/a>div classoffcanvas-inner>div classsp-module >div classsp-module-content>ul classmenu>li classitem-101 default current active>a href/index.php >Home/a>/li>li classitem-178>a href/index.php/about-niropharm >About Us/a>/li>li classitem-181>a href/index.php/news-blog >News Blog/a>/li>li classitem-180>a href/index.php/contact >Contact Us/a>/li>/ul>/div>/div>/div>/div>!-- Go to top -->a href# classsp-scroll-up aria-labelScroll Up>span classfa fa-chevron-up aria-hiddentrue>/span>/a>script typeapplication/javascript src/media/plg_jchoptimize/cache/js/215d9612f4f0681c4c53b26f201089c1.js defer >/script>script src/components/com_sppagebuilder/assets/js/sppagebuilder.js?f7a307d5d6b1748af3468afbea376c25 deferdefer typetext/javascript>/script>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Fri, 25 Oct 2024 16:37:43 GMTContent-Type: text/html; charsetutf-8Content-Length: 28462Connection: keep-aliveServer: ApacheX-Powered-By: PHP/7.4.10Set-Cookie: a7f1eeda1b6f9b7c5ce2803e0595a7d18bog25a84j4c1nt7gi68u8pb2q49trqb; path/; HttpOnlyX-Logged-In: FalseX-Content-Powered-By: K2 v2.10.3 (by JoomlaWorks)Expires: Wed, 17 Aug 2005 00:00:00 GMTLast-Modified: Fri, 25 Oct 2024 16:37:43 GMTCache-Control: no-store, no-cache, must-revalidate, post-check0, pre-check0Pragma: no-cacheAge: 1 !doctype html>html prefixog: http://ogp.me/ns# langen-gb dirltr>head>meta charsetutf-8>meta nameviewport contentwidthdevice-width, initial-scale1, shrink-to-fitno>link relcanonical hrefhttps://antispam.niropharm.org/>base hrefhttps://antispam.niropharm.org/ />meta http-equivcontent-type contenttext/html; charsetutf-8 />meta namedescription contentDemo Helix />meta namegenerator contentHELIX_ULTIMATE_GENERATOR_TEXT />title>Niropharm - Home/title>link href/images/loginNlogin.png relshortcut icon typeimage/vnd.microsoft.icon />link relstylesheet typetext/css href/media/plg_jchoptimize/cache/css/5878ea71e7700911ebf994b442e10210.css />script typeapplication/json classjoomla-script-options new>{csrf.token:5daef23f638ab7137e4de9fa5583c341,data:{breakpoints:{tablet:991,mobile:480},header:{stickyOffset:100}},system.paths:{root:,base:}}/script>meta propertyog:title contentHome />meta propertyog:type contentwebsite />meta propertyog:url contenthttps://antispam.niropharm.org/ />meta propertyog:site_name contentNiropharm />meta nametwitter:card contentsummary />meta nametwitter:site contentNiropharm />/head>body classsite helix-ultimate hu com-sppagebuilder view-page layout-default task-none itemid-101 en-gb ltr sticky-header layout-fluid offcanvas-init offcanvs-position-right>div classbody-wrapper>div classbody-innerwrapper>header idsp-header>div classcontainer>div classcontainer-inner>div classrow>div idsp-logo classcol-8 col-lg-3>div classsp-column>div classlogo>a href/>img classlogo-image d-none d-lg-inline-block src/images/nirophlogo.jpg altNiropharm>img classlogo-image-phone d-inline-block d-lg-none src/images/nirophlogo.jpg altNiropharm>/a>/div>/div>/div>div idsp-menu classcol-4 col-lg-9>div classsp-column>nav classsp-megamenu-wrapper rolenavigation>a idoffcanvas-toggler aria-labelNavigation classoffcanvas-toggler-right href#>i classfa fa-bars aria-hiddentrue titleNavigation>/i>/a>ul classsp-megamenu-parent menu-animation-fade-up d-none d-lg-block>li classsp-menu-item current-item active>a aria-currentpage href/index.php >Home/a>/li>li classsp-menu-item>a href/index.php/about-niropharm >About Us/a>/li>li classsp-menu-item>a href/index.php/news-blog >News Blog/a>/li>li classsp-menu-item>a href/index.php/contact >Contact Us/a>/li>/ul>/nav>/div>/div>/div>/div>/div>/header>section idsp-section-1 >div classrow>div idsp-title classcol-lg-12 >div classsp-column >/div>/div>/div>/section>section idsp-main-body >div classrow>main idsp-component classcol-lg-12 >div classsp-column >div idsystem-message-container>/div>div idsp-page-builder classsp-page-builder page-1>div classpage-content>section idlt-slider classsppb-section lt-slider >div classsppb-row-overlay>/div>div classsppb-row-container>div classsppb-row>div classsppb-col-sm-12 idcolumn-wrap-id-1511613809>div idcolumn-id-1511613809 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587056618327 classsppb-addon-wrapper>div idsppb-addon-1587056618327 classclearfix >div classsppb-addon sppb-addon-module >div classsppb-addon-content>!-- START REVOLUTION SLIDER 5.0.16 fullwidth mode -->div idrev_slider_1_1_wrapper classrev_slider_wrapper fullwidthbanner-container stylemargin:0px auto;background-color:#E9E9E9;padding:0px;margin-top:0px;margin-bottom:0px;max-height:730px;>div idrev_slider_1_1 classrev_slider fullwidthabanner styledisplay:none;max-height:730px;height:730px;>ul> !-- SLIDE 1-->li data-transitionfade data-slotamount7 data-masterspeed300 data-thumbhttps://antispam.niropharm.org/images/uniterevolution/home-slider/slide1.jpg data-saveperformanceoff idlt-slider data-titleSlide>!-- MAIN IMAGE -->img srchttps://antispam.niropharm.org/images/uniterevolution/home-slider/slide1.jpg altslide1 data-bgpositioncenter top data-bgfitcover data-bgrepeatno-repeat>!-- LAYERS -->!-- LAYER NR. 1 -->div classtp-caption medium_light_white tp-fade tp-resizeme lt-slider-color data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 5; max-width: none; max-height: none; white-space: nowrap;>Forward thinking for your /div>!-- LAYER NR. 2 -->div classtp-caption roundedimage tp-fade tp-resizeme data-x150 data-ycenter data-voffset7 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 6; max-width: 700px; max-height: none; white-space: normal;>Etiam scelerisque tortor at lectus dapibus, nec fermentum diam feugiat.Morbi rutrum magna et dui feugiat, non tristique mi convallis liquam. /div>!-- LAYER NR. 3 -->div classtp-caption large_bold_black sfr tp-resizeme data-x150 data-ycenter data-voffset-82 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 7; max-width: none; max-height: none; white-space: nowrap;>better incomes /div>!-- LAYER NR. 4 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn left data-x150 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 8; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/about-niropharm > Read More/a>/div>!-- LAYER NR. 5 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn right data-x350 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 9; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/contact > Contact Us/a>/div>!-- LAYER NR. 6 -->div classtp-caption tp-fade data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 10;>img srchttps://antispam.niropharm.org/images/uniterevolution/home-slider/business-home-rev-slider-07.png alt>/div>!-- LAYER NR. 7 -->div classtp-caption sfr lt-slider-img-bottom data-x-137 data-y668 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 11;>img srchttps://antispam.niropharm.org/images/uniterevolution/home-slider/main-home-rev-slider-img-02.png alt data-ww1690 data-hh62>/div>/li>!-- SLIDE 2-->li data-transitionfade data-slotamount7 data-masterspeed300 data-thumbhttps://antispam.niropharm.org/images/uniterevolution/home-slider/slide2.jpg data-saveperformanceoff idlt-slider data-titleSlide>!-- MAIN IMAGE -->img srchttps://antispam.niropharm.org/images/uniterevolution/home-slider/slide2.jpg altslide2 data-bgpositioncenter top data-bgfitcover data-bgrepeatno-repeat>!-- LAYERS -->!-- LAYER NR. 1 -->div classtp-caption medium_light_white tp-fade tp-resizeme lt-slider-color data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 5; max-width: none; max-height: none; white-space: nowrap;>We are mainly focused on making /div>!-- LAYER NR. 2 -->div classtp-caption roundedimage tp-fade tp-resizeme data-x150 data-ycenter data-voffset7 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 6; max-width: 700px; max-height: none; white-space: normal;>Etiam scelerisque tortor at lectus dapibus, nec fermentum diam feugiat.Morbi rutrum magna et dui feugiat, non tristique mi convallis liquam. /div>!-- LAYER NR. 3 -->div classtp-caption large_bold_black sfr tp-resizeme data-x150 data-ycenter data-voffset-82 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 7; max-width: none; max-height: none; white-space: nowrap;>your company better /div>!-- LAYER NR. 4 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn left data-x150 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 8; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/pages/our-services > Read More/a>/div>!-- LAYER NR. 5 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn right data-x350 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 9; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/contact > Contact Us/a>/div>!-- LAYER NR. 6 -->div classtp-caption tp-fade data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 10;>img srchttps://antispam.niropharm.org/images/uniterevolution/home-slider/business-home-rev-slider-07.png alt>/div>!-- LAYER NR. 7 -->div classtp-caption sfr lt-slider-img-bottom data-x-137 data-y668 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 11;>img srchttps://antispam.niropharm.org/images/uniterevolution/home-slider/main-home-rev-slider-img-02.png alt data-ww1690 data-hh62>/div>/li>!-- SLIDE 3-->li data-transitionfade data-slotamount7 data-masterspeed300 data-thumbhttps://antispam.niropharm.org/images/uniterevolution/home-slider/slide3.jpg data-saveperformanceoff idlt-slider data-titleSlide>!-- MAIN IMAGE -->img srchttps://antispam.niropharm.org/images/uniterevolution/home-slider/slide3.jpg altslide3 data-bgpositioncenter top data-bgfitcover data-bgrepeatno-repeat>!-- LAYERS -->!-- LAYER NR. 1 -->div classtp-caption medium_light_white tp-fade tp-resizeme lt-slider-color data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 5; max-width: none; max-height: none; white-space: nowrap;>BEST OF Business Planning /div>!-- LAYER NR. 2 -->div classtp-caption roundedimage tp-fade tp-resizeme data-x150 data-ycenter data-voffset7 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 6; max-width: 700px; max-height: none; white-space: normal;>Etiam scelerisque tortor at lectus dapibus, nec fermentum diam feugiat.Morbi rutrum magna et dui feugiat, non tristique mi convallis liquam. /div>!-- LAYER NR. 3 -->div classtp-caption large_bold_black sfr tp-resizeme data-x150 data-ycenter data-voffset-82 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 7; max-width: none; max-height: none; white-space: nowrap;>Advisors & Specialists /div>!-- LAYER NR. 4 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn left data-x150 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 8; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/pages/about-us > Read More/a>/div>!-- LAYER NR. 5 -->div classtp-caption excerpt tp-fade tp-resizeme lt-slider-btn right data-x350 data-ycenter data-voffset100 data-speed300 data-start500 data-easingPower3.easeInOut data-splitinnone data-splitoutnone data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 9; max-width: none; max-height: none; white-space: nowrap;>a href/index.php/contact > Contact Us/a>/div>!-- LAYER NR. 6 -->div classtp-caption tp-fade data-x150 data-ycenter data-voffset-160 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 10;>img srchttps://antispam.niropharm.org/images/uniterevolution/home-slider/business-home-rev-slider-07.png alt>/div>!-- LAYER NR. 7 -->div classtp-caption sfr lt-slider-img-bottom data-x-137 data-y668 data-speed300 data-start500 data-easingPower3.easeInOut data-elementdelay0.1 data-endelementdelay0.1 data-endspeed300 stylez-index: 11;>img srchttps://antispam.niropharm.org/images/uniterevolution/home-slider/main-home-rev-slider-img-02.png alt data-ww1690 data-hh62>/div>/li>/ul>div classtp-bannertimer tp-bottom styledisplay:none; visibility: hidden !important;>/div> /div>/div>!-- END REVOLUTION SLIDER --> /div>/div>/div>/div>/div>/div>/div>/div>/div>/section>section idlt-service classsppb-section lt-service lt-blog sppb-section-content-center >div classsppb-row-overlay>/div>div classsppb-row-container>div classsppb-section-title sppb-text-left>h2 classsppb-title-heading>NEWS/h2>p classsppb-title-subheading>PHARMA IN THE NEWS/p>/div>div classsppb-row sppb-align-center>div classsppb-col-md-12 idcolumn-wrap-id-1519278520250>div idcolumn-id-1519278520250 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587096872075 classsppb-addon-wrapper>div idsppb-addon-1587096872075 classclearfix >div classsppb-addon sppb-addon-module >div classsppb-addon-content>div idk2ModuleBox103 classk2ItemsBlock>ul>li classeven>!-- Plugins: BeforeDisplay -->!-- K2 Plugins: K2BeforeDisplay -->a classmoduleItemTitle href/index.php/news-blog/item/736-new-lung-cancer-drug-cuts-death-risk-by-half-study-finds>New Lung cancer drug cuts death risk by half, study finds/a>!-- Plugins: AfterDisplayTitle -->!-- K2 Plugins: K2AfterDisplayTitle -->!-- Plugins: BeforeDisplayContent -->!-- K2 Plugins: K2BeforeDisplayContent -->div classmoduleItemIntrotext>a classmoduleItemImage href/index.php/news-blog/item/736-new-lung-cancer-drug-cuts-death-risk-by-half-study-finds titleContinue reading "New Lung cancer drug cuts death risk by half, study finds">img src/media/k2/items/cache/3de37b3f2de6564a2ea064ec2afe25d4_M.jpg altNew Lung cancer drug cuts death risk by half, study finds />/a>/div>div classclr>/div>div classclr>/div>!-- Plugins: AfterDisplayContent -->!-- K2 Plugins: K2AfterDisplayContent -->span classmoduleItemDateCreated> Written on Monday, 05 June 2023 15:06 /span>a classmoduleItemReadMore href/index.php/news-blog/item/736-new-lung-cancer-drug-cuts-death-risk-by-half-study-finds> Read more... /a>!-- Plugins: AfterDisplay -->!-- K2 Plugins: K2AfterDisplay -->div classclr>/div>/li>li classodd>!-- Plugins: BeforeDisplay -->!-- K2 Plugins: K2BeforeDisplay -->a classmoduleItemTitle href/index.php/news-blog/item/735-group-urges-tinubu-to-strengthen-implement-tobacco-control-laws>Group urges Tinubu to strengthen, implement tobacco control laws/a>!-- Plugins: AfterDisplayTitle -->!-- K2 Plugins: K2AfterDisplayTitle -->!-- Plugins: BeforeDisplayContent -->!-- K2 Plugins: K2BeforeDisplayContent -->div classmoduleItemIntrotext>a classmoduleItemImage href/index.php/news-blog/item/735-group-urges-tinubu-to-strengthen-implement-tobacco-control-laws titleContinue reading "Group urges Tinubu to strengthen, implement tobacco control laws">img src/media/k2/items/cache/4c704b823894e663c696fb5ee0a8793f_M.jpg?t20230602_124754 altGroup urges Tinubu to strengthen, implement tobacco control laws />/a>/div>div classclr>/div>div classclr>/div>!-- Plugins: AfterDisplayContent -->!-- K2 Plugins: K2AfterDisplayContent -->span classmoduleItemDateCreated> Written on Friday, 02 June 2023 12:36 /span>a classmoduleItemReadMore href/index.php/news-blog/item/735-group-urges-tinubu-to-strengthen-implement-tobacco-control-laws> Read more... /a>!-- Plugins: AfterDisplay -->!-- K2 Plugins: K2AfterDisplay -->div classclr>/div>/li>li classeven lastItem>!-- Plugins: BeforeDisplay -->!-- K2 Plugins: K2BeforeDisplay -->a classmoduleItemTitle href/index.php/news-blog/item/734-prioritise-local-drug-manufacturing-health-insurance-stakeholders-task-tinubu>Prioritise local drug manufacturing, health insurance, stakeholders task Tinubu/a>!-- Plugins: AfterDisplayTitle -->!-- K2 Plugins: K2AfterDisplayTitle -->!-- Plugins: BeforeDisplayContent -->!-- K2 Plugins: K2BeforeDisplayContent -->div classmoduleItemIntrotext>a classmoduleItemImage href/index.php/news-blog/item/734-prioritise-local-drug-manufacturing-health-insurance-stakeholders-task-tinubu titleContinue reading "Prioritise local drug manufacturing, health insurance, stakeholders task Tinubu">img src/media/k2/items/cache/52847945d34c24d045f4f6bfeae5a17d_M.jpg?t20230601_071355 altPrioritise local drug manufacturing, health insurance, stakeholders task Tinubu />/a>/div>div classclr>/div>div classclr>/div>!-- Plugins: AfterDisplayContent -->!-- K2 Plugins: K2AfterDisplayContent -->span classmoduleItemDateCreated> Written on Wednesday, 31 May 2023 12:57 /span>a classmoduleItemReadMore href/index.php/news-blog/item/734-prioritise-local-drug-manufacturing-health-insurance-stakeholders-task-tinubu> Read more... /a>!-- Plugins: AfterDisplay -->!-- K2 Plugins: K2AfterDisplay -->div classclr>/div>/li>li classclearList>/li>/ul>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/section>section idlt-project classsppb-section lt-project >div classsppb-row-overlay>/div>div classsppb-row-container>div classsppb-row>div classsppb-col-md-6 idcolumn-wrap-id-1587310143530>div idcolumn-id-1587310143530 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587310143535 classsppb-addon-wrapper>div idsppb-addon-1587310143535 classclearfix >div classsppb-addon sppb-addon-single-image sppb-text-center lt-project-img>div classsppb-addon-content>div classsppb-addon-single-image-container>img classsppb-img-responsive src/images/2021/07/12/home1c.png altPresident giving a speech during the donation of COVID19 Relief Drugs to FG title loadinglazy>/div>/div>/div>/div>/div>div idsppb-addon-wrapper-1587321820480 classsppb-addon-wrapper>div idsppb-addon-1587321820480 classclearfix >div classsppb-addon sppb-addon-single-image sppb-text-center lt-project-img-pen>div classsppb-addon-content>div classsppb-addon-single-image-container>img classsppb-img-responsive src/images/2020/04/19/business-home-rev-slider-img-05.png altImage title loadinglazy>/div>/div>/div>/div>/div>/div>/div>/div>div classsppb-col-md-6 idcolumn-wrap-id-1587310143531>div idcolumn-id-1587310143531 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587310143541 classsppb-addon-wrapper>div idsppb-addon-1587310143541 classclearfix >div classsppb-addon sppb-addon-text-block lt-project-content lt-title-content>h5 classsppb-addon-title>A Responsible, Active and People FocusedHealthcare Advocacy Organisation. /h5>div classsppb-addon-content>h2>Developing people. Delivering results./h2>p>Niropharm member organizations believe in working to improve healthcare indices and take active practical steps to support and be corporately responsible for the health of the citizens in very direct and tangible ways. /p>/div>/div>/div>/div>div idsppb-addon-wrapper-1587318290840 classsppb-addon-wrapper>div idsppb-addon-1587318290840 classclearfix >div classsppb-text-left>a href/index.php/pages/about-us idbtn-1587318290840 classsppb-btn lt-btn sppb-btn-default sppb-btn-rounded>Read More/a>/div>/div>/div>/div>/div>/div>/div>/div>/section>section idlt-about classsppb-section lt-about >div classsppb-row-overlay>/div>div classsppb-row-container>div classsppb-row>div classsppb-col-md-4 idcolumn-wrap-id-1519278764263>div idcolumn-id-1519278764263 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1519279129419 classsppb-addon-wrapper>div idsppb-addon-1519279129419 classclearfix >div classsppb-addon sppb-addon-feature sppb-text-left lt-about-item>div classsppb-addon-content sppb-text-left>div classsppb-media>div classpull-left>div classsppb-icon>span classsppb-icon-container aria-labelMarket Size>i classfa fa-street-view aria-hiddentrue>/i>/span>/div>/div>div classsppb-media-body>div classsppb-media-content>h3 classsppb-addon-title sppb-feature-box-title sppb-media-heading>Market Size/h3>div classsppb-addon-text>NIROPHARM Market Size in Nigeria is $218m (source BMI monitor, 2006) and this is constantly growing due to the opportunities and market potentials./div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>div classsppb-col-md-4 idcolumn-wrap-id-1519278764264>div idcolumn-id-1519278764264 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587321820472 classsppb-addon-wrapper>div idsppb-addon-1587321820472 classclearfix >div classsppb-addon sppb-addon-feature sppb-text-left lt-about-item>div classsppb-addon-content sppb-text-left>div classsppb-media>div classpull-left>div classsppb-icon>span classsppb-icon-container aria-labelPharma Imports>i classfas fa-funnel-dollar aria-hiddentrue>/i>/span>/div>/div>div classsppb-media-body>div classsppb-media-content>h3 classsppb-addon-title sppb-feature-box-title sppb-media-heading>Pharma Imports/h3>div classsppb-addon-text>Imports of Pharmaceutical products constitute 70% of the Nigerian Pharma industry./div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>div classsppb-col-md-4 idcolumn-wrap-id-1519278764265>div idcolumn-id-1519278764265 classsppb-column >div classsppb-column-addons>div idsppb-addon-wrapper-1587321820469 classsppb-addon-wrapper>div idsppb-addon-1587321820469 classclearfix >div classsppb-addon sppb-addon-feature sppb-text-left lt-about-item>div classsppb-addon-content sppb-text-left>div classsppb-media>div classpull-left>div classsppb-icon>span classsppb-icon-container aria-labelLocal Manufacture>i classfas fa-mortar-pestle aria-hiddentrue>/i>/span>/div>/div>div classsppb-media-body>div classsppb-media-content>h3 classsppb-addon-title sppb-feature-box-title sppb-media-heading>Local Manufacture/h3>div classsppb-addon-text>Local Manufacture accounts for the remaining 30% of pharmaceuticals in the country/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/div>/section>/div>/div>/div>/main>/div>/section>section idsp-bottom >div classcontainer>div classcontainer-inner>div classrow>div idsp-bottom1 classcol-sm-col-sm-6 col-lg-12 >div classsp-column >div classsp-module >h3 classsp-module-title>Information/h3>div classsp-module-content>div classcustom >p>strong>NIROPHARM/strong> is dedicated to working to improve and enhance the quality of service to the Nation, public (local and international) Image, and the scope of the Nigerian Pharmaceutical Industry who face a number of challenges. /p>p>Some of the challenges that NIROPHRM is set to tackle with all the resources it has at its disposal include: High cost of funds, Poor infrastructure, Poor IPR protection, Chaotic drug distribution, Lack of data for planning, High level of Counterfeiting, Low capacity of Regulatory Agencies, Regulatory Agency, not computerized, Poor surveillance particularly at the land borders/p>/div>/div>/div>/div>/div>/div>/div>/div>/section>footer idsp-footer >div classcontainer>div classcontainer-inner>div classrow>div idsp-footer1 classcol-lg-12 >div classsp-column >span classsp-copyright>div aligncenter>a target_blank titleDesigned and Powered by hrefhttps://www.tishritechnologies.com relauthor nofollow>Tishri InfoTech Nig Ltd/a>/div>/span>/div>/div>/div>/div>/div>/footer> /div>/div>!-- Off Canvas Menu -->div classoffcanvas-overlay>/div>div classoffcanvas-menu>a href# classclose-offcanvas>span classfa fa-remove>/span>/a>div classoffcanvas-inner>div classsp-module >div classsp-module-content>ul classmenu>li classitem-101 default current active>a href/index.php >Home/a>/li>li classitem-178>a href/index.php/about-niropharm >About Us/a>/li>li classitem-181>a href/index.php/news-blog >News Blog/a>/li>li classitem-180>a href/index.php/contact >Contact Us/a>/li>/ul>/div>/div>/div>/div>!-- Go to top -->a href# classsp-scroll-up aria-labelScroll Up>span classfa fa-chevron-up aria-hiddentrue>/span>/a>script typeapplication/javascript src/media/plg_jchoptimize/cache/js/70014ebb99980cc32e8ed5952b580e43.js defer >/script>script src/components/com_sppagebuilder/assets/js/sppagebuilder.js?f7a307d5d6b1748af3468afbea376c25 deferdefer typetext/javascript>/script>/body>/html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]